WHO WE ARE
Presidio Medical is a clinical-stage, privately held medical device company developing a transformational neuromodulation technology platform. Our first indication in the treatment of chronic pain.
Presidio Medical Announces New Executive Appointment
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Presidio Medical, Inc., a clinical-stage medical device company developing a neuromodulation platform, today announced that Katherine H. Neuenfeldt has joined the Executive Team as Vice President, Marketing. “We are thrilled toLEARN MORE
Presidio Medical Announces $30 Million Financing Round Led by Invus Opportunities
SOUTH SAN FRANCISCO, Calif., July 14, 2020 – Presidio Medical, Inc., a clinical-stage medical device company developing a neuromodulation platform technology with an initial indication to treat chronic pain, today announced it has closed $30LEARN MORE